Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up.
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
[Natalizumab and reduction of carbonylated proteins in patients with multiple sclerosis].
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Natalizumab in relapsing-remitting multiple sclerosis.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Biomarkers for multiple sclerosis.
Tamoxifen Promotes Axonal Preservation and Gait Locomotion Recovery after Spinal Cord Injury in Cats.
Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
HyperCKemia Related to the Initial and Recurrent Attacks of Neuromyelitis Optica.
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Pages
« first
‹ previous
…
157
158
159
160
161
162
163
164
165
…
next ›
last »